Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Methods for Measuring the Orientation and Rotation Rate of 3D-printed Particles in Turbulence.

Cole BC, Marcus GG, Parsa S, Kramel S, Ni R, Voth GA.

J Vis Exp. 2016 Jun 24;(112). doi: 10.3791/53599.

2.

A potential pathogenic factor from Mycoplasma hominis is a TLR2-dependent, macrophage-activating, P50-related adhesin.

Hasebe A, Mu HH, Cole BC.

Am J Reprod Immunol. 2014 Sep;72(3):285-95. doi: 10.1111/aji.12279. Epub 2014 Jun 17.

PMID:
24938999
3.

Mycoplasma superantigen initiates a TLR4-dependent Th17 cascade that enhances arthritis after blocking B7-1 in Mycoplasma arthritidis-infected mice.

Mu HH, Nourian MM, Jiang HH, Tran JW, Cole BC.

Cell Microbiol. 2014 Jun;16(6):896-911. doi: 10.1111/cmi.12247. Epub 2014 Jan 6.

PMID:
24298898
4.

Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL-17 and Th17-associated cytokines.

Mu HH, Hasebe A, Van Schelt A, Cole BC.

Cell Microbiol. 2011 Mar;13(3):374-87. doi: 10.1111/j.1462-5822.2010.01540.x. Epub 2010 Nov 11.

PMID:
20946245
5.

Characterization of the macrophage-stimulating activity from Ureaplasma urealyticum.

Peltier MR, Freeman AJ, Mu HH, Cole BC.

Am J Reprod Immunol. 2007 Mar;57(3):186-92.

PMID:
17295897
6.

Inflammatory lipoproteins purified from a toxigenic and arthritogenic strain of Mycoplasma arthritidis are dependent on Toll-like receptor 2 and CD14.

Hasebe A, Mu HH, Washburn LR, Chan FV, Pennock ND, Taylor ML, Cole BC.

Infect Immun. 2007 Apr;75(4):1820-6. Epub 2007 Feb 5.

7.

Superantigens and autoimmune disease: are they involved?

Sawitzke AD, Mu HH, Cole BC.

Curr Opin Infect Dis. 1999 Jun;12(3):213-9.

PMID:
17035782
8.

A microbial TLR2 agonist imparts macrophage-activating ability to apolipoprotein A-1.

Hasebe A, Pennock ND, Mu HH, Chan FV, Taylor ML, Cole BC.

J Immunol. 2006 Oct 1;177(7):4826-32.

10.

Characterization and partial purification of a macrophage-stimulating factor from Mycoplasma hominis.

Peltier MR, Freeman AJ, Mu HH, Cole BC.

Am J Reprod Immunol. 2005 Dec;54(6):342-51.

PMID:
16305659
12.

Engagement of Toll-like receptors by mycoplasmal superantigen: downregulation of TLR2 by MAM/TLR4 interaction.

Mu HH, Pennock ND, Humphreys J, Kirschning CJ, Cole BC.

Cell Microbiol. 2005 Jun;7(6):789-97.

PMID:
15888082
14.

The mycoplasma superantigen MAM: role in arthritis and immune-mediated disease.

Cole BC, Mu HH, Sawitzke AD.

Int J Med Microbiol. 2000 Oct;290(4-5):489-90. No abstract available.

PMID:
11111931
16.

Mycoplasma-induced arthritis in animals: relevance to understanding the etiologies of the human rheumatic diseases.

Cole BC.

Rev Rhum Engl Ed. 1999 Jan 30;66(1 Suppl):45S-49S. Review. No abstract available.

PMID:
10063525
17.
18.

Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Cole BC, Sawitzke AD, Ahmed EA, Atkin CL, David CS.

Infect Immun. 1997 Oct;65(10):4190-8. Erratum in: Infect Immun 1998 May;66(5):2399.

19.

The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens.

Cole BC, Knudtson KL, Oliphant A, Sawitzke AD, Pole A, Manohar M, Benson LS, Ahmed E, Atkin CL.

J Exp Med. 1996 Mar 1;183(3):1105-10.

20.

Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

D'Orazio JA, Cole BC, Stein-Streilein J.

Infect Immun. 1996 Feb;64(2):441-7.

21.
22.

Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate.

Cannon GW, Marble DA, Griffiths MM, Cole BC, McCall S, Schulman SF, Strand V.

J Rheumatol. 1995 Feb;22(2):207-13.

PMID:
7537827
23.
24.

Human T-cell responses to Mycoplasma arthritidis-derived superantigen.

Bhardwaj N, Hodtsev AS, Nisanian A, Kabak S, Friedman SM, Cole BC, Posnett DN.

Infect Immun. 1994 Jan;62(1):135-44.

25.

The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.

Chu ZT, Carswell-Crumpton C, Cole BC, Jones PP.

Immunogenetics. 1994;40(1):9-20.

PMID:
8206532
26.

Interaction of Mycoplasma arthritidis superantigen with human T cells.

Posnett DN, Hodtsev AS, Kabak S, Friedman SM, Cole BC, Bhardwaj N.

Clin Infect Dis. 1993 Aug;17 Suppl 1:S170-5.

PMID:
8399910
27.

Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.

Cole BC, Ahmed E, Araneo BA, Shelby J, Kamerath C, Wei S, McCall S, Atkin CL.

Clin Infect Dis. 1993 Aug;17 Suppl 1:S163-9.

PMID:
8399909
28.

Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM.

Cole BC, Griffiths MM.

Arthritis Rheum. 1993 Jul;36(7):994-1002.

PMID:
8318046
29.

Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen.

Cole BC, Balderas RA, Ahmed EA, Kono D, Theofilopoulos AN.

J Immunol. 1993 Apr 15;150(8 Pt 1):3291-9.

PMID:
8468471
30.

Effects of gold sodium thiomalate, cyclosporin A, cyclophosphamide, and placebo on collagen-induced arthritis in rats.

Cannon GW, McCall S, Cole BC, Radov LA, Ward JR, Griffiths MM.

Agents Actions. 1993 Mar;38(3-4):240-6.

PMID:
8213350
31.

T-cell receptors and collagen induced arthritis in H-2r mice.

Griffiths MM, Cole BC, Ito J, Harper DS, Anderson GD, Cannon GW, Luthra HS, David CS.

Autoimmunity. 1993;14(3):221-9.

PMID:
8329559
32.

Mycoplasma arthritidis mitogen. V beta engaged in mice, rats, and humans, and requirement of HLA-DR alpha for presentation.

Baccala R, Smith LR, Vestberg M, Peterson PA, Cole BC, Theofilopoulos AN.

Arthritis Rheum. 1992 Apr;35(4):434-42.

PMID:
1533125
33.

Dendritic cells are potent antigen-presenting cells for microbial superantigens.

Bhardwaj N, Friedman SM, Cole BC, Nisanian AJ.

J Exp Med. 1992 Jan 1;175(1):267-73.

34.
36.

The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.

Cole BC, Atkin CL.

Immunol Today. 1991 Aug;12(8):271-6. Review.

PMID:
1910449
37.

T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses.

Tumang JR, Cherniack EP, Gietl DM, Cole BC, Russo C, Crow MK, Friedman SM.

J Immunol. 1991 Jul 15;147(2):432-8.

PMID:
1830062
38.

A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease.

Friedman SM, Posnett DN, Tumang JR, Cole BC, Crow MK.

Arthritis Rheum. 1991 Apr;34(4):468-80. Review.

PMID:
1826427
39.

The immunobiology of Mycoplasma arthritidis and its superantigen MAM.

Cole BC.

Curr Top Microbiol Immunol. 1991;174:107-19. Review. No abstract available.

PMID:
1802617
40.

Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge.

Tumang JR, Posnett DN, Cole BC, Crow MK, Friedman SM.

J Exp Med. 1990 Jun 1;171(6):2153-8.

41.

Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice.

Cannon GW, McCall S, Cole BC, Griffiths MM, Radov LA, Ward JR.

Agents Actions. 1990 Mar;29(3-4):315-23.

PMID:
2339671
42.
46.

Expression of metabolism-inhibition antibodies against Mycoplasma arthritidis in rats.

Washburn LR, Cole BC, Ward JR.

Am J Vet Res. 1988 Jan;49(1):52-7.

PMID:
3354967
47.

Arthritogenic effects of Mycoplasma arthritidis T cell mitogen in rats.

Cannon GW, Cole BC, Ward JR, Smith JL, Eichwald EJ.

J Rheumatol. 1988;15(5):735-41.

PMID:
3262748
48.
50.

Genetic control of T cell activation induced by Mycoplasma arthritidis.

Cole BC.

Isr J Med Sci. 1987 May;23(5):496-502. Review.

PMID:
3312095

Supplemental Content

Support Center